论文部分内容阅读
观察精纯抗栓酶治疗早期脑梗死的疗效、安全性及溶栓治疗前后血浆D－二聚体的变化。将80例早期脑梗死病人随机分为治疗组和对照组，分别给予精纯抗栓酶和复方丹参治疗。对治疗前后患者神经功能进行评定，并检测血浆D－二聚体水平。结果显示应用精纯抗栓酶后患者症状明显改善，总有效率达92．5％，与对照组相比P＜0．01；治疗组血浆D－二聚体明显升高，P＜0．01。提示精统抗栓酶治疗早期脑梗死疗效高，安全性好。
To observe the efficacy and safety of antithrombotic enzyme in the treatment of early cerebral infarction and the changes of plasma D-dimer before and after thrombolytic therapy. 80 patients with early cerebral infarction were randomly divided into treatment group and control group, respectively, given pure antithrombotic enzyme and compound Salvia treatment. The neurological function was evaluated before and after treatment and plasma D-dimer level was measured. The results showed that the application of pure antithrombotic patients significantly improved the symptoms, the total effective rate was 92.5%, compared with the control group P <0.01; treatment group plasma D-dimer was significantly increased, P <0. 01. Tip precision antithrombotic treatment of early cerebral infarction, high efficacy, good safety.